{
    "Symbol": "RDY",
    "AssetType": "Common Stock",
    "Name": "Dr. Reddy\u2019s Laboratories Ltd ADR",
    "Description": "Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.",
    "CIK": "1135951",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "8-2-337, ROAD NO.3 BANJARA HILLS, HYDERABAD, IN",
    "FiscalYearEnd": "March",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "13744958000",
    "EBITDA": "79539003000",
    "PERatio": "20.74",
    "PEGRatio": "4.713",
    "BookValue": "1769.05",
    "DividendPerShare": "40",
    "DividendYield": "0.0058",
    "EPS": "3.98",
    "RevenuePerShareTTM": "289.4",
    "ProfitMargin": "0.193",
    "OperatingMarginTTM": "0.234",
    "ReturnOnAssetsTTM": "0.109",
    "ReturnOnEquityTTM": "0.206",
    "RevenueTTM": "288507003000",
    "GrossProfitTTM": "113840000000",
    "DilutedEPSTTM": "3.98",
    "QuarterlyEarningsGrowthYOY": "-0.009",
    "QuarterlyRevenueGrowthYOY": "0.139",
    "AnalystTargetPrice": "85.7",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "1",
    "AnalystRatingHold": "1",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "20.74",
    "ForwardPE": "19.53",
    "PriceToSalesRatioTTM": "0.0448",
    "PriceToBookRatio": "3.704",
    "EVToRevenue": "0.0425",
    "EVToEBITDA": "0.136",
    "Beta": "0.345",
    "52WeekHigh": "83.25",
    "52WeekLow": "62.97",
    "50DayMovingAverage": "74.84",
    "200DayMovingAverage": "71.69",
    "SharesOutstanding": "166545000",
    "DividendDate": "2023-08-11",
    "ExDividendDate": "2024-07-30"
}